Presentation Information

[O01-12]Ustekinumab and low-dose Upadacitinib combination therapy in medically difficult-to-treat patients with Crohn’s disease: a real-world single-center respective cohort study

*Xiaolei Wang1, Xiaoli Zhu1 (1. Department of Gastroenterology, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, China)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Comment

To browse or post comments, you must log in.Log in